Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

If the progression assessments for the two metrics

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 480
Posts 80,989
Boards Moderated 22
Alias Born 09/05/02
160x600 placeholder
EBay said it plans to spin off its PayPal business into a separate publicly traded company next year, a victory for activist investor Carl Icahn, who had pushed for the company to split.
More Top Equities Stories Of The Day
JAL Customer Data Target of Cyber Attack
Tibco Software to be Taken Private
IPO Scorecard: Update on Selected Initial Stock Offerings
Bank Branches in U.S. Dip to Lowest Since 2005
Bank Branches in U.S. Decline to Lowest Level Since 2005
Intel Invests in Chinese Chip Maker -- Update
Starboard Pushes For Potential Yahoo-AOL Tie-Up -- 5th Update
Correction to Dow Index Overseers Correction
DewDiligence Member Level  Thursday, 05/24/12 02:22:04 PM
Re: jq1234 post# 142539
Post # of 182306 
If the progression assessments for the two metrics are made on the same schedule for every patient, it shouldn’t be possible for PFS to be greater than TTP. A death in between progression assessments ought not to cause a patient to be deleted from the TTP dataset, but rather for TTP to be censored at the time of death.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist